CVS Health Reaffirms FY22 Outlook

Ahead of its meetings with investors later in June, CVS Health (CVS) on Thursday reaffirmed its earnings and adjusted earnings guidance for the full-year 2022.

For fiscal 2022, the company continues to project earnings in the range of $6.93 to $7.13 per share and adjusted earnings in the range of $8.20 to $8.40 per share.

The company had in early December 2021 projected total revenues for the full-year 2022 to be between $304.0 billion and $309.0 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $8.36 per share on revenues of $308.88 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT